• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study.

作者信息

Makhoul Imad R, Peleg Ofra, Miller Benjamin, Bar-Oz Benjamin, Kochavi Orna, Mechoulam Hadas, Mezer Eedy, Ulanovsky Irena, Smolkin Tatiana, Yahalom Claudia, Khoury Asaad, Lorber Avraham, Nir Amiram, Blazer Shraga

出版信息

Arch Dis Child. 2013 Jul;98(7):565-7. doi: 10.1136/archdischild-2013-303951. Epub 2013 Apr 30.

DOI:10.1136/archdischild-2013-303951
PMID:23632260
Abstract
摘要

相似文献

1
Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study.口服普萘洛尔与安慰剂治疗早产儿视网膜病变：一项前瞻性、随机、双盲试点研究。
Arch Dis Child. 2013 Jul;98(7):565-7. doi: 10.1136/archdischild-2013-303951. Epub 2013 Apr 30.
2
Oral Propranolol: A New Treatment for Infants with Retinopathy of Prematurity?口服普萘洛尔：治疗早产儿视网膜病变的新方法？
Neonatology. 2015;108(1):49-52. doi: 10.1159/000381659. Epub 2015 May 9.
3
Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.口服普萘洛尔治疗早产儿视网膜病变：风险、安全性问题及展望。
J Pediatr. 2013 Dec;163(6):1570-1577.e6. doi: 10.1016/j.jpeds.2013.07.049. Epub 2013 Sep 18.
4
[Propranolol as a possible new pharmacologic treatment of retinopathy of prematurity].[普萘洛尔作为早产儿视网膜病变一种可能的新药物治疗方法]
Zhonghua Er Ke Za Zhi. 2015 Jul;53(7):555-7.
5
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial.0.1%普萘洛尔眼药水用于早产儿视网膜病变新生儿：一项初步临床试验
Pediatr Res. 2017 Feb;81(2):307-314. doi: 10.1038/pr.2016.230. Epub 2016 Nov 4.
6
Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age.
Br J Dermatol. 2013 Jul;169(1):181-3. doi: 10.1111/bjd.12217.
7
Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial.维生素E预防早产儿视网膜病变的疗效与安全性：一项随机、对照、双盲试验
Pediatrics. 1987 Apr;79(4):489-500.
8
Treating infants with 0.2% propranolol eye micro-drops drastically reduced the progression of retinopathy of prematurity.用0.2%普萘洛尔眼微滴剂治疗婴儿可显著降低早产儿视网膜病变的进展。
Acta Paediatr. 2023 Sep;112(9):1905-1906. doi: 10.1111/apa.16850. Epub 2023 May 24.
9
Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms.
Int Angiol. 1999 Mar;18(1):52-7.
10
Oral D-penicillamine for the prevention of retinopathy of prematurity in very low birth weight infants: a randomized, placebo-controlled trial.口服 D-青霉胺预防极低出生体重儿早产儿视网膜病变：一项随机、安慰剂对照试验。
Acta Paediatr. 2010 Sep;99(9):1324-8. doi: 10.1111/j.1651-2227.2010.01837.x.

引用本文的文献

1
[Advances in pharmacological research for retinopathy of prematurity].[早产儿视网膜病变的药理学研究进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 May 25;54(3):411-421. doi: 10.3724/zdxbyxb-2024-0216.
2
Retinopathy of prematurity in the era of precision neonatology: from risk stratification to targeted therapies.精准新生儿学时代的早产儿视网膜病变：从风险分层到靶向治疗
World J Pediatr. 2025 May 17. doi: 10.1007/s12519-025-00919-1.
3
Comparison of Different Doses of Oral and Ocular Propranolol for Retinopathy of Prematurity: A Network Meta-Analysis.
不同剂量口服和眼部普萘洛尔治疗早产儿视网膜病变的比较：一项网状 Meta 分析。
Paediatr Drugs. 2024 Sep;26(5):499-518. doi: 10.1007/s40272-024-00647-5. Epub 2024 Aug 7.
4
β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation.新生儿脐带血中β3肾上腺素能受体分析（β3 RECORD）：一项初步临床研究的研究方案
Life (Basel). 2024 Jun 19;14(6):776. doi: 10.3390/life14060776.
5
Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression.普萘洛尔：一种对抗早产儿视网膜病变进展的新药理学方法。
Front Pediatr. 2024 Jan 16;12:1322783. doi: 10.3389/fped.2024.1322783. eCollection 2024.
6
Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors.将氧分压与视网膜血管生成解耦作为早产儿视网膜病变管理的新视角。β-肾上腺素能受体带来的新机遇。
Front Pharmacol. 2022 Jan 21;13:835771. doi: 10.3389/fphar.2022.835771. eCollection 2022.
7
β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo.β3-肾上腺素能受体，从新生儿疾病到癌症的往返旅程中的新角色：胚胎提供的暗示线索。
Med Res Rev. 2022 May;42(3):1179-1201. doi: 10.1002/med.21874. Epub 2021 Dec 29.
8
Clinical Efficacy and Safety of Propranolol in the Prevention and Treatment of Retinopathy of Prematurity: A Meta-Analysis of Randomized Controlled Trials.普萘洛尔预防和治疗早产儿视网膜病变的临床疗效及安全性：一项随机对照试验的Meta分析
Front Pediatr. 2021 Feb 10;9:631673. doi: 10.3389/fped.2021.631673. eCollection 2021.
9
Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again.早产儿视网膜病变的转化研究：从床边到实验室再回归床边
J Clin Med. 2021 Jan 18;10(2):331. doi: 10.3390/jcm10020331.
10
Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions.早产儿视网膜病变预防的当前证据与成果：洞察母体和胎盘的新作用
Explor Med. 2020;1:4-26. doi: 10.37349/emed.2020.00002. Epub 2020 Feb 29.